Update on the management of inflammatory bowel disease: specific role of adalimumab

Update on the management of inflammatory bowel disease: specific role of adalimumab

Luisa Guidi, Daniela Pugliese, Alessandro ArmuzziInternal Medicine and Gastroenterology, Complesso Integrato Columbus, Universit&agrave; Cattolica del Sacro Cuore, Rome, ItalyAbstract: Anti-tumor necrosis factor alpha (TNF-a) medications are a class of biologics employed in the treatment of...

Full description

Bibliographic Details
Main Authors:	Guidi L, Pugliese D, Armuzzi A
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-07-01
Series:	Clinical and Experimental Gastroenterology
Online Access:	http://www.dovepress.com/update-on-the-management-of-inflammatory-bowel-disease-specific-role-o-a7879

Similar Items

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
by: Giuseppe Privitera, et al.
Published: (2021-02-01)

Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease
by: Marta Vernero, et al.
Published: (2023-10-01)

Adalimumab induced psoriasis during the treatment of inflammatory bowel disease – case report
by: Edyta Lelonek, et al.
Published: (2015-09-01)

Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)
by: Valeria Dipasquale, et al.
Published: (2024-02-01)

Genetics of inflammatory bowel disease--an update.
by: van Heel, D, et al.
Published: (2001)

Adalimumab Persistence and Its Biosimilar in Inflammatory Bowel Disease: A Real-World Study
by: María Carmen Fernández-Cano, et al.
Published: (2024-01-01)

Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease
by: Silvia Marquez-Megias, et al.
Published: (2021-08-01)

Immunology of inflammatory bowel disease--an update.
by: Jewell, D
Published: (1995)

Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
by: Giammarco Mocci, et al.
Published: (2022-07-01)

Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
by: Rochelle Wong, et al.
Published: (2023-10-01)

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
by: Zvonimir Petric, et al.
Published: (2022-08-01)

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study
by: Fang Wang, et al.
Published: (2023-10-01)

Outcomes of Continuation vs Discontinuation of Adalimumab Therapy During Third Trimester of Pregnancy in Inflammatory Bowel Disease
by: Brindusa Truta, et al.
Published: (2022-01-01)

Safety profile and side effects of infliximab and adalimumab in inflammatory bowel disease at a referral center in northeastern Brazil
by: Joelma Aurélio de Sousa Santos, et al.
Published: (2024-02-01)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
by: Roberto Gabbiadini, et al.
Published: (2023-05-01)

An Update on the Role of Extracellular Vesicles in the Pathogenesis of Necrotizing Enterocolitis and Inflammatory Bowel Diseases
by: Rafał Filip
Published: (2021-11-01)

Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2022-12-01)

Genetics on early onset inflammatory bowel disease: An update
by: Johnson Nameirakpam, et al.
Published: (2020-03-01)

The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review
by: Nariman Hossein-Javaheri, et al.
Published: (2023-08-01)

Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis
by: Han Wang, et al.
Published: (2022-11-01)

Technological advances in inflammatory bowel disease endoscopy and histology
by: Ludovico Alfarone, et al.
Published: (2022-11-01)

The role of phagocytes in inflammatory bowel disease.
by: Hermanowicz, A, et al.
Published: (1985)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
by: Carla Felice, et al.
Published: (2023-02-01)

IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
by: Wordsworth, P, et al.
Published: (2009)

Inflammatory bowel disease and risk of dementia: An updated meta-analysis
by: Nanyang Liu, et al.
Published: (2022-10-01)

The role of cytokines in inflammatory bowel disease.
by: Radford-Smith, G, et al.
Published: (1994)

Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It
by: Giulia Migliorisi, et al.
Published: (2024-01-01)

Incident Colorectal Cancer in Inflammatory Bowel Disease
by: Benedetto Neri, et al.
Published: (2022-01-01)

Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease
by: Aranzazu Jauregui-Amezaga, et al.
Published: (2021-06-01)

An Update on the Role and Potential Molecules in Relation to Ruminococcus gnavus in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus
by: Hong J, et al.
Published: (2024-03-01)

The role of macrophages in inflammatory bowel diseases.
by: Heinsbroek, SE, et al.
Published: (2009)

Inflammatory Bowel Diseases: An Updated Overview on the Heat Shock Protein Involvement
by: Federica Scalia, et al.
Published: (2023-07-01)

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
by: Bourreille, A, et al.
Published: (2009)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
by: Hengameh Chloé Mirsepasi-Lauridsen, et al.
Published: (2018-11-01)

Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
by: Rudwaleit, M, et al.
Published: (2008)

Conventional medical management of inflammatory bowel disease.
by: Burger, D, et al.
Published: (2011)

The role of apoptosis of enterocytes in inflammatory bowel diseases
by: N. Yu. Matveeva, et al.
Published: (2018-03-01)

Investigating the Role of Gastrointestinal-Specific Anxiety and Perceived Disability in the Adjustment to Inflammatory Bowel Disease
by: Angela Seaman, et al.
Published: (2024-02-01)

The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
by: Gabrielle Wark, et al.
Published: (2020-12-01)

A review of the role of intermittent fasting in the management of inflammatory bowel disease
by: Celeste M. Lavallee, et al.
Published: (2023-05-01)